John Burns
Director Financiero/CFO en SELLAS LIFE SCIENCES GROUP, INC. .
Fortuna: 39 368 $ al 30/04/2024
Cargos activos de John Burns
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Comptroller/Controller/Auditor | 30/12/2017 | - |
| Director Financiero/CFO | 30/12/2017 | - |
Historial de carrera de John Burns
Antiguos cargos conocidos de John Burns.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PIXELWORKS, INC. | Corporate Officer/Principal | - | - |
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | 23/02/2016 | - |
Formación de John Burns.
| Tulane University (Louisiana) | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Comptroller/Controller/Auditor | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
| Electronic Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PIXELWORKS, INC. | Electronic Technology |
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
- Bolsa de valores
- Insiders
- John Burns
- Experiencia